Gland Pharma jumped 4.80 per cent to ₹1,790.40, the highest level since December 3, 2025, on the National Stock Exchange.

remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...

Solana holds below $130 as supply continues to overwhelm demand on Monday. The 100-day EMA confirms a Death Cross pattern after crossing below the 200-day EMA on the daily chart. SOL ETFs extended ...

Nifty extended losses for the third straight session, trading below its 50-day exponential moving average (EMA) and signalling continued weakness in the market. Among sectors, Nifty Metal and PSU Bank ...

Abstract: This paper presents a rigorous mathematical analysis of the higher-order serial differentiator (HOSD), originally proposed by the authors for estimating time derivatives of time-varying ...

Econometric Theory provides an authoritative outlet for original contributions in all of the major areas of econometrics. As well as articles that embody original theoretical research, the journal ...

As we look ahead to 2025, the derivatives market is set to experience another pivotal year of regulatory transformation. Regulatory compliance is no longer a ‘one-and-done’ project. It has become a ...

There are a variety of pre-trade and derivatives trading tools that help examine market sentiment and formulate options strategies. This analysis explores such tools using the September 2024 Hong Kong ...

MUMBAI, Oct 1 (Reuters) - India's market regulator tightened the rules for equity derivatives trading on Tuesday, raising the entry barrier and making it more costly to trade in the asset class, ...